Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.

[1]  H. Boushey,et al.  Mechanism of cough and bronchoconstriction induced by distilled water aerosol. , 2015, The American review of respiratory disease.

[2]  Ming-Jium Shieh,et al.  Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer. , 2008, Biomaterials.

[3]  T. Wiedmann,et al.  Performance of the vibrating membrane aerosol generation device: Aeroneb Micropump Nebulizer. , 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[4]  J. Benoit,et al.  Lipid nanocapsules for intracellular drug delivery of anticancer drugs. , 2007, Journal of nanoscience and nanotechnology.

[5]  T. Stinchcombe,et al.  Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel. , 2007, Nanomedicine.

[6]  J. Benoit,et al.  Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. , 2006, Journal of biomedical materials research. Part A.

[7]  M. Gulisano,et al.  Lyoprotected nanosphere formulations for paclitaxel controlled delivery. , 2006, Journal of nanoscience and nanotechnology.

[8]  S. Rault,et al.  Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent. , 2006, International journal of pharmaceutics.

[9]  R. Löbenberg,et al.  Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. , 2006, International journal of pharmaceutics.

[10]  J. Benoit,et al.  A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats , 2006, Molecular Cancer Therapeutics.

[11]  W. Couet,et al.  Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules , 2006, Pharmaceutical Research.

[12]  J. Benoit,et al.  Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[13]  J. Leroux,et al.  Long Circulating Poly(Ethylene Glycol)-Decorated Lipid Nanocapsules Deliver Docetaxel to Solid Tumors , 2006, Pharmaceutical Research.

[14]  G. Smaldone.  Advances in aerosols: adult respiratory disease. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[15]  A. R. Kulkarni,et al.  Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. , 2006, Biomaterials.

[16]  J. Benoit,et al.  99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  E. Lemarié,et al.  Aerosol delivery of chemotherapy in an orthotopic model of lung cancer , 2005, European Respiratory Journal.

[18]  V. Knight,et al.  A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture. , 2005, Journal of the American Chemical Society.

[19]  D. Bazile,et al.  Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying , 2005, Pharmaceutical Research.

[20]  Y. Zou,et al.  Antitumor Activity of Hydrophilic Paclitaxel Copolymer Prodrug Using Locoregional Delivery in Human Orthotopic Non–Small Cell Lung Cancer Xenograft Models , 2004, Clinical Cancer Research.

[21]  J. Benoit,et al.  Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. , 2004, International journal of pharmaceutics.

[22]  A. Gautam,et al.  Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery. , 2003, Current cancer drug targets.

[23]  J. Benoit,et al.  New lipid nanocapsules exhibit sustained release properties for amiodarone. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[24]  J. Benoit,et al.  A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers , 2002, Pharmaceutical Research.

[25]  E. Golunski,et al.  Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  M. Kris,et al.  Development of inhalational agents for oncologic use. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. Hershey,et al.  Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  Shigeo Sato,et al.  Anti‐tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts , 1997, Japanese journal of cancer research : Gann.

[29]  J. Beijnen,et al.  Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Au,et al.  Differential Effect of Taxol in Rat Primary and Metastatic Prostate Tumors: Site-Dependent Pharmacodynamics , 1996, Pharmaceutical Research.

[31]  R. Straubinger,et al.  Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. , 1993, Cancer research.

[32]  T. Riss,et al.  Comparison of MTT, XTT, and a novel tetrazolium compound MTS for in vitro proliferation and chemosensitivity assays , 1992 .

[33]  M. Stearns,et al.  Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. , 1992, Cancer research.

[34]  J. G. Cory,et al.  Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. , 1991, Cancer communications.

[35]  J. Balmes,et al.  Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols. , 1988, The American review of respiratory disease.

[36]  H. Boushey,et al.  Alteration in osmolarity of inhaled aerosols cause bronchoconstriction and cough, but absence of a permeant anion causes cough alone. , 1984, The American review of respiratory disease.

[37]  P. Diot,et al.  Aerosolized chemotherapy. , 2008, Journal of aerosol medicine and pulmonary drug delivery.

[38]  R. Panchagnula,et al.  Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. , 2007, The Journal of investigative dermatology.

[39]  M. Miric,et al.  Risk of acute bronchospasm and bronchial hyperreactivity from inhaled acid aerosol in healthy subjects: randomized, double-blind controlled trial. , 2004, Croatian medical journal.

[40]  S. Parangi,et al.  Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. , 1997, Cancer research.

[41]  R. Straubinger,et al.  Novel Taxol formulations: Taxol-containing liposomes. , 1993, Journal of the National Cancer Institute. Monographs.

[42]  C. Mascoli,et al.  Applications and advantages of the Limulus amebocyte lysate (LAL) pyrogen test for parenteral injectable products. , 1979, Progress in clinical and biological research.